EUCTR2010-022027-30-BE进行中（未招募）不适用
A randomized placebo-controlled double blind study to prevent BOS - VIT001
Z Gasthuisberg0 个研究点开始时间: 2010年9月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Stable LTx recipients at discharge after transplantation.
- •Signed informed consent
- •Adult (age at least 18 years old at moment of transplantation)
- •Able to take oral medication
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prolonged and/or complicated ICU-course after transplantation.
- •Early (<30 days post-transplant) post-operative death
- •Major suture problems (airway stenosis or stent)
- •Retransplantation (lung)
- •Previous transplantation (solid organ)
- •Multi-organ transplantation (lung+ other solid organ)
研究者
相似试验
进行中（未招募）
不适用
A randomized placebo-controlled double blind study to treat BOS.-Mortality at 1 and 2 year post diagnosis of BOS-Infection rate during BOS-Evolution of pulmonary function after diagnosis of BOSMedDRA version: 12.1Level: LLTClassification code 10029888Term: Obliterative bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10049202Term: Bronchiolitis obliteransMedDRA version: 12.1Level: LLTClassification code 10068805Term: Follicular bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10019319Term: Heart-lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10025127Term: Lung transplantMedDRA version: 12.1Level: LLTClassification code 10051604Term: Lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10056409Term: Heart and lung transplantMedDRA version: 12.1Level: LLTClassification code 10016547Term: FEVMedDRA version: 12.1Level: LLTClassification code 10016549Term: FEV 1 abnormalMedDRA version: 12.1Level: LLTClassification code 10016550Term: FEV 1 decreasedMedDRA version: 12.1Level: LLTClassification code 10016553Term: FEV 1 lowEUCTR2010-021983-14-BEZ Gasthuisberg30
已完成
3 期
A double blind randomized placebo controlled study on the efficacy of intralymphatic immunotherapy in the treatment of grasspollen induced allergic rhinitis.Allergic rhino-conjunctivitishayfever1000170810046304NL-OMON39544HagaZiekenhuis50
撤回
2 期
A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjectsobesitasimpaired glucose tolerance1001842410019654Insulin resistanceNL-OMON37344Academisch Medisch Centrum20
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”Atopic dermatitisEUCTR2018-004705-26-ESSanofi Aventis Groupe188
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patientsAtopic dermatitisEUCTR2018-004705-26-ITSANOFI-AVENTIS GROUPE188